Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal lanosterol 14α-demethylase is a cytochrome P450 enzyme (CYP51) that catalyzes the removal of the 14α-methyl group from lanosterol, a crucial step in ergosterol biosynthesis. It is a primary target for azole antifungals, which inhibit its activity, leading to ergosterol depletion and fungal cell death. Resistance can develop through mutations, overexpression, or efflux pump upregulation.
Inhibition of lanosterol 14α-demethylase, leading to ergosterol depletion and accumulation of toxic sterol intermediates.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal Lanosterol 14α-Demethylase.